"Polyethylene Glycols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
| Descriptor ID |
D011092
|
| MeSH Number(s) |
D02.033.455.250.700 D05.750.741 D25.720.741 J01.637.051.720.741
|
| Concept/Terms |
Polyethylene Glycols- Polyethylene Glycols
- Macrogols
- Macrogol
- Polyethylene Glycol
- Glycol, Polyethylene
- Glycols, Polyethylene
- Polyethylene Oxide
- Oxide, Polyethylene
- Oxides, Polyethylene
- Polyethylene Oxides
- Polyethyleneoxide
- Polyethyleneoxides
- Polyoxyethylenes
- Polyoxyethylene
- Tritons
|
Below are MeSH descriptors whose meaning is more general than "Polyethylene Glycols".
Below are MeSH descriptors whose meaning is more specific than "Polyethylene Glycols".
This graph shows the total number of publications written about "Polyethylene Glycols" by people in this website by year, and whether "Polyethylene Glycols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 6 | 3 | 9 |
| 2008 | 2 | 1 | 3 |
| 2009 | 4 | 4 | 8 |
| 2010 | 5 | 3 | 8 |
| 2011 | 6 | 8 | 14 |
| 2012 | 9 | 7 | 16 |
| 2013 | 14 | 1 | 15 |
| 2014 | 6 | 6 | 12 |
| 2015 | 6 | 7 | 13 |
| 2016 | 4 | 3 | 7 |
| 2017 | 4 | 5 | 9 |
| 2018 | 2 | 7 | 9 |
| 2019 | 5 | 2 | 7 |
| 2020 | 4 | 4 | 8 |
| 2021 | 2 | 5 | 7 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 2 | 3 |
| 2025 | 3 | 3 | 6 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyethylene Glycols" by people in Profiles.
-
Comparing various bowel preparation regimens in constipated patients undergoing colonoscopy: A systematic review and network meta-analysis of randomised controlled trials. Colorectal Dis. 2026 Feb; 28(2):e70399.
-
An Ultralong-Circulating Tantalum-Based Computed Tomography Contrast Agent for Vascular Imaging in Large Animals. ACS Nano. 2026 Jan 13; 20(1):507-521.
-
Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. Ophthalmology. 2026 Apr; 133(4):451-465.
-
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry. J Child Neurol. 2026 Apr; 41(4):545-555.
-
Rational Design of PEGylated Nanogels: Optimization of Degree of PEGylation and Development of a Novel Enzyme-Responsive Grafted Layer. Int J Pharm. 2025 Nov 10; 684:126102.
-
Tumor pH-triggered PEG detachable nanoparticles for TLR7/8 agonist delivery to improve cancer immunotherapy. Biomater Sci. 2025 May 13; 13(10):2794-2805.
-
Loss of Socs2 improves molecular responses to IFNa in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F. Leukemia. 2025 Apr; 39(4):876-887.
-
Citrulline and ADI-PEG20 reduce inflammation in a juvenile porcine model of acute endotoxemia. Front Immunol. 2024; 15:1400574.
-
Loss of Dnmt3a increases self-renewal and resistance to pegIFN-a in JAK2-V617F-positive myeloproliferative neoplasms. Blood. 2024 06 13; 143(24):2490-2503.
-
Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. ACS Appl Mater Interfaces. 2024 May 22; 16(20):25665-25675.